WINDLAS BIOTECH LIMITED (WINDLAS)

NSE: ₹811.15
BSE: ₹810.50
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 144.79 152.67 162.21 171.29 175.15 187.00 195.02 202.71 210.09 222.40 233.10 238.50
YOY Revenue Growth % 20.72% 15.02% 35.51% 21.73% 20.97% 22.49% 20.22% 18.34% 19.95% 18.93% 19.53% 17.66%
Other Income 2.62 3.24 3.16 4.44 4.13 4.84 4.11 4.94 5.24 3.65 4.57 4.35
Total Income 147.41 155.91 165.38 175.73 179.29 191.84 199.13 207.64 215.33 226.04 237.67 242.85
Total Expenses + 131.07 137.60 145.57 153.09 160.98 171.56 178.79 186.82 192.07 202.46 217.70 222.69
Cost of Materials Consumed 1.98 4.35 -5.43 2.06 -2.26 0.38 0.88 3.33 6.11 8.04 -5.47 3.78
Employee Benefit Expense 20.56 21.32 22.73 22.85 27.85 30.97 32.17 31.93 32.23 36.45 42.05 41.37
Other Expenses 15.58 16.80 17.50 19.28 17.02 16.56 17.39 20.04 21.61 20.45 23.18 24.79
Operating Profit 13.72 15.07 16.64 18.19 14.18 15.45 16.23 15.89 18.02 19.94 15.40 15.81
OPM % 9.5% 9.9% 10.3% 10.6% 8.1% 8.3% 8.3% 7.8% 8.6% 9% 6.6% 6.6%
Profit Before Tax + 16.34 18.31 19.81 22.63 18.31 20.29 20.34 20.82 23.26 23.59 19.97 20.16
Tax Expense 4.28 4.28 4.71 5.64 4.83 4.63 4.76 4.54 5.59 5.79 4.97 4.17
Tax % 26.2% 23.4% 23.8% 24.9% 26.4% 22.8% 23.4% 21.8% 24% 24.5% 24.9% 20.7%
Profit After Tax 12.07 14.03 15.10 16.99 13.48 15.66 15.58 16.28 17.66 17.80 15.00 15.99
EPS (Basic) 5.79 6.75 7.26 8.17 6.47 7.49 7.45 7.77 8.43 8.48 7.12 7.58

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022
Revenue from Operations 904.09 759.88 630.96 513.08 465.93
YOY Revenue Growth % 18.98% 20.43% 22.97% 10.12% -
Other Income 17.80 18.02 13.47 9.97 6.71
Total Income 921.89 777.90 644.42 523.05 472.64
Total Expenses + 834.92 698.14 567.33 466.01 427.07
Cost of Materials Consumed 12.46 2.33 2.96 -0.76 307.56
Employee Benefit Expense 152.09 122.92 87.46 70.32 63.41
Other Expenses 90.02 71.00 69.15 57.09 47.28
Operating Profit 69.17 61.74 63.62 47.07 38.86
OPM % 7.7% 8.1% 10.1% 9.2% 8.3%
Profit Before Exceptional 86.98 79.76 77.09 57.04 45.57
Exceptional Items 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 86.98 79.76 77.09 57.04 45.57
Tax Expense 20.52 18.76 18.90 14.41 7.48
Tax % 23.6% 23.5% 24.5% 25.3% 16.4%
Profit After Tax 66.46 60.99 58.19 42.63 38.09
EPS (Basic) 31.60 29.19 27.97 19.70 18.80

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022
ASSETS
Non-Current Assets + 280.50 235.32 194.92 175.44 109.36
Property, Plant & Equipment 187.18 195.49 169.49 102.60 90.73
Capital Work in Progress 56.16 3.20 5.71 13.80 7.58
Non-Current Investments 0.00 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 26.14 27.89 9.56 6.81 0.45
Current Assets + 626.85 525.13 431.29 353.54 381.65
Inventories 61.82 81.38 62.19 74.74 58.71
Trade Receivables 227.40 166.86 136.28 116.86 110.77
Cash and Cash Equivalents 0.54 0.42 5.29 3.69 0.57
Current Investments 268.37 223.37 173.44 106.51 64.82
LIABILITIES & EQUITY
Total Equity 580.84 505.77 449.94 402.27 394.78
Equity Share Capital 10.55 10.48 10.40 10.46 10.90
Other Equity 570.29 495.29 439.54 391.81 383.88
Non-Current Liabilities 5.58 5.24 4.52 5.46 2.25
Current Liabilities 320.93 249.44 171.75 121.24 93.99
Total Liabilities 326.51 254.68 176.27 126.70 96.23

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022
Cash from Operating Activities 104.93 68.19 108.96 60.97 9.13
Cash from Investing Activities -91.79 -74.06 -92.07 -14.11 -154.58
Cash from Financing Activities -13.03 1.01 -15.29 -43.74 130.09
Net Increase/Decrease in Cash 0.11 -4.86 1.60 3.12 -15.36